The EORTC Phase III trials in prostatic cancer.
D002369:Castration; D002986:Clinical Trials as Topic; D003534:Cyproterone / Q000008:administration & dosage / Q000627:therapeutic use*; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000627:therapeutic use*; D004961:Estramustine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011897:Random Allocation
D009588:Nitrogen Mustard Compounds; D004961:Estramustine; D004054:Diethylstilbestrol; D003534:Cyproterone; D008525:Medroxyprogesterone